Related references
Note: Only part of the references are listed.Out-patient' albumin dialysis for cholestatic patients with intractable pruritus
P. Leckie et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions
Andreas E. Kremer et al.
HEPATOLOGY (2012)
Autotaxin expression from synovial fibroblasts is essential for the pathogenesis of modeled arthritis
Ioanna Nikitopoulou et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2012)
Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus
Andreas E. Kremer et al.
GASTROENTEROLOGY (2010)
Autotaxin-an LPA producing enzyme with diverse functions
Keita Nakanaga et al.
JOURNAL OF BIOCHEMISTRY (2010)
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation
Harald M. H. G. Albers et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
Rifampin is safe for treatment of pruritus due to chronic cholestasis: a meta-analysis of prospective randomized-controlled trials
Sandeep Khurana et al.
LIVER INTERNATIONAL (2006)
Fatigue in primary biliary cirrhosis is associated with excessive daytime somnolence
Julia L. Newton et al.
HEPATOLOGY (2006)
Frequent cellular senescence in small bile ducts in primary biliary cirrhosis: a possible role in bile duct loss
M Sasaki et al.
JOURNAL OF PATHOLOGY (2005)
Quality of life in patients with primary biliary cirrhosis
RE Poupon et al.
HEPATOLOGY (2004)
The emerging role of lysophosphatidic acid in cancer
GB Mills et al.
NATURE REVIEWS CANCER (2003)
Pain as a complication of use of opiate antagonists for symptom control in cholestasis
CA McRae et al.
GASTROENTEROLOGY (2003)
Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis
MI Prince et al.
GUT (2002)
Share Paper
